NCT04895735 2026-02-02MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland CancerMayo ClinicPhase 2 Active not recruiting45 enrolled
NCT04209660 2025-10-07Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland CancersMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting64 enrolled